Breaking News

Codexis, Novartis Ink Tech Transfer and License Agreement

Novartis to leverage CodeEvolver protein engineering platform technology develop performance enzymes for use in manufacturing

Author Image

By: Kristin Brooks

Managing Editor, Contract Pharma

Codexis, Inc. has signed a CodeEvolver platform agreement with Novartis under which Codexis has granted a non-exclusive license to its CodeEvolver protein engineering platform technology to Novartis to develop performance enzymes for use in manufacturing pharmaceutical products. Upon completion of the technology transfer, the CodeEvolver protein engineering platform will be located at a Novartis site.   Novartis will pay Codexis an upfront payment, milestone payments upon the satisfactory comp...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters